Literature DB >> 18403944

Gluten tolerance in adult patients with celiac disease 20 years after diagnosis?

Erica G D Hopman1, Mary E von Blomberg, Manou R Batstra, Hans Morreau, Friedo W Dekker, Frits Koning, Cor B H W Lamers, Maria Luisa Mearin.   

Abstract

BACKGROUND AND
OBJECTIVE: Celiac disease (CD) is believed to be a permanent intolerance to gluten. A number of patients, however, discontinue the gluten-free diet (GFD) without developing symptoms or signs. The aim of our study was to investigate whether CD patients are capable of developing tolerance to gluten.
METHODS: All 77 adult patients from our hospital known to have biopsy-proven CD for more than 10 years were invited to participate. We investigated symptoms, gluten consumption, antibodies for CD and other autoimmunity, human leukocyte antigen (HLA)-typing, bone mineral density, and performed small bowel biopsies. Tolerance was defined as no immunological or histological signs of CD while consuming gluten.
RESULTS: Sixty-six patients accepted participation, but after review of the diagnostic biopsies 53 were found to have true CD. Twenty-three percent of patients had a gluten-containing diet, 15% admitted gluten transgression and 62% followed the GFD. Patients on a GFD had significantly more osteoporosis. Normal small bowel mucosa was found in four of eight on gluten-containing diet and in four of four with gluten transgression. Two patients were considered to have developed tolerance to gluten. One of them was HLA-DQ2/DQ8 negative.
CONCLUSION: Development of tolerance to gluten seems possible in some patients with CD. Further follow-up will show whether this tolerance is permanent or only a long-term return to latency. This feature may be associated with genetic characteristics, especially with HLA genotypes that differ from DQ2 or DQ8. More insight into the mechanisms of the development of gluten tolerance may help to distinguish those CD patients that might not require life-long GFD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18403944     DOI: 10.1097/MEG.0b013e3282f4de6e

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  8 in total

1.  Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet.

Authors:  Alberto Rubio-Tapia; Mussarat W Rahim; Jacalyn A See; Brian D Lahr; Tsung-Teh Wu; Joseph A Murray
Journal:  Am J Gastroenterol       Date:  2010-02-09       Impact factor: 10.864

Review 2.  Review article: coeliac disease, new approaches to therapy.

Authors:  S Rashtak; J A Murray
Journal:  Aliment Pharmacol Ther       Date:  2012-02-13       Impact factor: 8.171

3.  Decreased prevalence of celiac disease among Brazilian elderly.

Authors:  Lucas Malta Almeida; Luiz Claudio Castro; Rosa Harumi Uenishi; Fernanda Coutinho de Almeida; Patricia Maria Fritsch; Lenora Gandolfi; Riccardo Pratesi; Yanna Karla de Medeiros Nóbrega
Journal:  World J Gastroenterol       Date:  2013-03-28       Impact factor: 5.742

Review 4.  Celiac disease: From pathophysiology to treatment.

Authors:  Ilaria Parzanese; Dorina Qehajaj; Federica Patrinicola; Merica Aralica; Maurizio Chiriva-Internati; Sanja Stifter; Luca Elli; Fabio Grizzi
Journal:  World J Gastrointest Pathophysiol       Date:  2017-05-15

Review 5.  Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review.

Authors:  Tiina Rauhavirta; Minna Hietikko; Teea Salmi; Katri Lindfors
Journal:  Clin Rev Allergy Immunol       Date:  2019-08       Impact factor: 10.817

Review 6.  Gluten tolerance; potential challenges in treatment strategies.

Authors:  Justine Bold; Kamran Rostami
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2011

Review 7.  Subclinical celiac disease and gluten sensitivity.

Authors:  Mohammad Rostami Nejad; Sabine Hogg-Kollars; Sauid Ishaq; Kamran Rostami
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2011

Review 8.  Gluten-Free Diet in Celiac Disease-Forever and for All?

Authors:  Alice Itzlinger; Federica Branchi; Luca Elli; Michael Schumann
Journal:  Nutrients       Date:  2018-11-18       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.